Live feed16:05:00·645dPRReleasevia QuantisnowVir Biotechnology Receives FDA Breakthrough Therapy Designation and EMA PRIME Designation for Tobevibart and Elebsiran in Chronic Hepatitis DeltaByQuantisnow·Wall Street's wire, on your screen.VIR· Vir Biotechnology Inc.Health Care
